Drug Repurposing Service Providers Market: Global Industry Analysis and Opportunity Assessment, 2020 – 2030
Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis

Repurposingof marketed / shelved / pipeline candidates for the treatment of diseases(different from original target indications) has emerged as a viable businessstrategy. The rising popularity of this approach can further be attributed tovarious benefits, such as reduced development timelines, decreased investmentsand relatively higher success rates (considering that the safety profiles ofsuch candidates have already been established).

RootsAnalysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service ProvidersMarket, 2020-2030.”

TheUSD 1.2 billion (by 2030) financial opportunity within the drug repurposingservice providers market has been analyzed across the following segments:

Typeof Repurposing Approaches

·       Disease-centric approach

·       Target-centric approach

·       Drug-centric approach

TherapeuticArea

·       Same Therapeutic Area

·       Different Therapeutic Area

Typeof Drug Molecule

·       Biologics

·       Small Molecule

KeyGeographical Region

·       North America

·       Europe

·       Asia-Pacific

TheDrug Repurposing Service Providers Market, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:

·       Auxillis Pharma

·       ChemBio Discovery Solutions

·       Excelra

·       GVK Bio

·       Iris Pharma

·       Lantern Pharma

·       PanXome

·       Pharmacelera

·       Physiogenex

·       Smart Pharma

·       Socium

·       SOM Biotech

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Role of Non-Profit /Academic Organizations

6. Company Profiles

7.  Partnerships

8. Big Pharma Initiatives

9. Case Study: DiscontinuedDrug Development Programs

10. Cost Saving Analysis

11. Market Forecast andOpportunity Analysis

12.  Covid-19 Impact on Drug Repurposing ServiceProviders Market

13. Recent Advancements andTrends in Outsourcing of Drug Repurposing

14. Interview Transcripts

15. Appendix 1: List ofPotential Drug-Indication Candidates for Drug Repurposing

16. Appendix 2: TabulatedData

17. Appendix 3: List ofCompanies and Organizations

Formore information, please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com